These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8551060)
1. Development of a new Prolifigen TPA IRMA assay using monoclonal anti-cytokeratin antibodies. Sundström BE; D'Amico Y; Brundell J Int J Biol Markers; 1995; 10(3):166-73. PubMed ID: 8551060 [TBL] [Abstract][Full Text] [Related]
2. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue. Gion M; Mione R; Barioli P; Sartorello P; Capitanio G Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):779-87. PubMed ID: 7865616 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen]. Hamase A; Kawanaka M; Kitani H; Fukuchi M Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689 [TBL] [Abstract][Full Text] [Related]
4. [A basic and clinical evaluation of a new immunoradiometric assay kit for human serum tissue polypeptide antigen (TPA)]. Shimojo K; Watanabe N; Sakai S; Kobayashi M; Ohtake H; Hatori N; Fukasawa K; Tomiyoshi K; Inoue T; Endo K Kaku Igaku; 1996 Jun; 33(6):655-61. PubMed ID: 8741511 [TBL] [Abstract][Full Text] [Related]
5. A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients. Silén A; Wiklund B; Andersson EL; Nilsson S Scand J Clin Lab Invest; 1995 Apr; 55(2):153-61. PubMed ID: 7545308 [TBL] [Abstract][Full Text] [Related]
6. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen. Correale M; Arnberg H; Blockx P; Bombardieri E; Castelli M; Encabo G; Gion M; Klapdor R; Martin M; Nilsson S Int J Biol Markers; 1994; 9(4):231-8. PubMed ID: 7836801 [TBL] [Abstract][Full Text] [Related]
7. Serum TPS versus TPA in Egyptian bladder cancer patients. Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P Int J Biol Markers; 1993; 8(4):221-6. PubMed ID: 7511149 [TBL] [Abstract][Full Text] [Related]
8. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer. Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer. Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A Anticancer Res; 1996; 16(6B):3793-8. PubMed ID: 9042259 [TBL] [Abstract][Full Text] [Related]
10. The tumor markers TPA, TPS, TPACYK and CYFRA 21-1 react differently with the keratins 8, 18 and 19. Bodenmüller H; Donié F; Kaufmann M; Banauch D Int J Biol Markers; 1994; 9(2):70-4. PubMed ID: 7523544 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"]. Sakahara H; Kousaka T; Hattori N; Hosono M; Kobayashi H; Shirato M; Yao Z; Konishi J Kaku Igaku; 1993 Dec; 30(12):1475-9. PubMed ID: 7509008 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop. Nap M; van Wel T; Andrés C; Bellanger L; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Meier T; Seguin P; Sjödin A; Stigbrand T; Sundström BE; van Dalen A; Wiebelhaus E; Wiklund B; Hilgers J Tumour Biol; 2001; 22(1):4-10. PubMed ID: 11054021 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Bonfrer JM; Groeneveld EM; Korse CM; van Dalen A; Oomen LC; Ivanyi D Tumour Biol; 1994; 15(4):210-22. PubMed ID: 7524130 [TBL] [Abstract][Full Text] [Related]
14. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565 [TBL] [Abstract][Full Text] [Related]
15. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit]. Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116 [TBL] [Abstract][Full Text] [Related]
16. In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens. Watanabe N; Oriuchi N; Higuchi T; Yukihiro M; Fukushima Y; Tomiyoshi K; Hirano T; Inoue T; Endo K Nucl Med Commun; 1998 Jan; 19(1):63-70. PubMed ID: 9515548 [TBL] [Abstract][Full Text] [Related]
17. Cytokeratins and tissue polypeptide antigen. Sundström BE; Stigbrand TI Int J Biol Markers; 1994; 9(2):102-8. PubMed ID: 7523541 [TBL] [Abstract][Full Text] [Related]
18. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit]. Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025 [TBL] [Abstract][Full Text] [Related]
19. On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18, and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum. Mellerick DM; Osborn M; Weber K Oncogene; 1990 Jul; 5(7):1007-17. PubMed ID: 1695723 [TBL] [Abstract][Full Text] [Related]
20. [An immunoradiometric assay of the serum TPA from patients with primary lung cancer and a comparison with the conventional double antibody method]. Suzuki K; Reshad K; Akiyama J; Itoi K; Hirata T; Muro K Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):703-11. PubMed ID: 2552212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]